Oxford Immunotec Global PLC·4

Jan 19, 5:06 PM ET

Oxford Immunotec Global PLC 4

4 · Oxford Immunotec Global PLC · Filed Jan 19, 2016

Insider Transaction Report

Form 4
Period: 2016-01-15
RANDALL PATRICIA
VP and General Counsel
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2016-01-15$0.09/sh+5,000$4508,650 total
  • Exercise/Conversion

    SHARE OPTION (RIGHT TO BUY)

    2016-01-155,00015,074 total
    Exercise: $0.09Exp: 2020-02-23Ordinary Shares (5,000 underlying)
Footnotes (1)
  • [F1]Became fully exercisable on April 1, 2014.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4